FDA Commissioner’s Rx For US Biosimilars Market: Reform Contracting Practices And Payment Models

 
• By Sue Sutter
  
Gottlieb at Bookings July 2018
FDA Commissioner Scott Gottlieb had some choice words for innovators at the unveiling of the Biosimilar Action Plan at the Brookings Institution.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business